Delving into the World of Protein Kinase Inhibitors BOSTON and ATLANTA, June 29, 2023 /PRNewswire/ — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company) Hey there, fellow readers! Today, we’re going to take a deep dive into the fascinating world of protein kinase inhibitors. But first, let’s talk about the recent announcement from Inhibikase Therapeutics,…
Welcome to our Blog! Market Update: Risk-Off Sentiment Drives Equities Lower The selling continues in equities as we are teeing up for more of a risk-off open in Europe today. Tech stocks were the only outlier yesterday but even they are holding lower as we approach the final stretch of the week. As with the…
Clever, Personable, and Unconventional: The Grandwest Enterprises Expansion Exciting News for Grandwest Enterprises Grandwest Enterprises recently made a bold move by adding the Sawtooth Expandable Tonneau to their product offerings. This innovative product, the Sawtooth STRETCH Tonneau, is now available throughout Canada thanks to this partnership. The logo of Grandwest Enterprises has always been synonymous…
Welcome to the Exclusive Political Soap Opera: Hon. Mapenduzi’s MoU Saga! The Background Story So, picture this: Hon. Ojara Martin Mapenduzi, the Bardege-Layibi Division Member of Parliament, decides to shake things up in the political arena by making a bold move. Drumroll please… he signs a Memorandum of Understanding (MoU) with none other than the…
Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology Patent Claims Describe a Novel System to Predict and Help Prevent Adverse Food Reactions Using Personal Medical Data The patent allowance received by Biomerica Inc. in China represents a significant milestone in the field of biomedical technology. The patent claims describe a…
23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today announced that 23andMe+ members now have exclusive access to four mental health reports to help determine their genetic likelihood of…
Welcome to the Bioasis Chronicles! Breaking News: Bioasis Provides Corporate Update and Announces Suspension of Operations Hey there, all you curious creatures of the biopharmaceutical world! It’s time for another dose of the Bioasis Chronicles, where we dive deep into the latest news from the innovative minds over at Bioasis Technologies Inc. Hold onto your…
Cognition Therapeutics Participates in Cantor Fitzgerald Brain Week 2023 Panel Purchase, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX) announced today that Lisa Ricciardi, president and chief executive officer, will be participating on a panel during Cantor Fitzgerald’s virtual Brain Week 2023 conference. The event is scheduled to take place from…
